APMD · Apnimed, Inc. · Analyst Estimates
$18.51
+1.92 (+11.54%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 8, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within the twelve months after the date that these consolidated financial statements are issued. The Company believes that its existing cash and cash equivalents of $172.8 million as of June 30, 2026, together with the additional proceeds received from the IPO, will be sufficient to allow the Company to fund operations at least twelve months from the date that the financial statements are issued.”View the 10-Q filed Sep 8, 2026
Market Cap
$771.42M
Shares
41.63M
Volume · Oct 20
311.11K
Avg daily vol (57 sessions)
525.16K
Analyst Estimates
Compare analyst forecasts for Apnimed, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-20 20:57 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.06
|
-0.06
|
-0.06
|
1
|
-0.21
|
0.00
|
0.00
|
0.00
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
84.80M
|
90.85M
|
96.90M
|
2
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-5.55
|
-3.98
|
-1.39
|
4
|
-3.98
|
-3.98
|
0.00
|
0.00
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
13.80M
|
22.44M
|
32.25M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.61
|
-0.60
|
-0.59
|
2
|
-0.60
|
-0.60
|
0.00
|
0.00
|
1
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.80
|
-0.72
|
-0.64
|
2
|
-0.72
|
-0.72
|
0.00
|
0.00
|
0
|
0
|
1
|
0
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
3
|
— | — | — | — | — | — | — | — |